These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19270513)

  • 21. High proportion of CD34+/CD38-cells is positively correlated with poor prognosis in newly diagnosed childhood acute lymphoblastic leukemia.
    Long J; Liu S; Li K; Zhou X; Zhang P; Zou L
    Leuk Lymphoma; 2014 Mar; 55(3):611-7. PubMed ID: 23706103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonotypic myeloma cells able to xenograft myeloma to nonobese diabetic severe combined immunodeficient mice copurify with CD34 (+) hematopoietic progenitors.
    Pilarski LM; Belch AR
    Clin Cancer Res; 2002 Oct; 8(10):3198-204. PubMed ID: 12374689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Distribution of antigenic aberration in the bone marrow of acute leukemia in complete remission].
    Shin S; Kahng J; Kim M; Lim J; Kim Y; Han K
    Korean J Lab Med; 2008 Feb; 28(1):1-7. PubMed ID: 18309249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells.
    Hotfilder M; Röttgers S; Rosemann A; Schrauder A; Schrappe M; Pieters R; Jürgens H; Harbott J; Vormoor J
    Cancer Res; 2005 Feb; 65(4):1442-9. PubMed ID: 15735032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plastic CD34 and CD38 expression in adult B-cell precursor acute lymphoblastic leukemia explains ambiguity of leukemia-initiating stem cell populations.
    Lang F; Wojcik B; Bothur S; Knecht C; Falkenburg JH; Schroeder T; Serve H; Ottmann OG; Rieger MA
    Leukemia; 2017 Mar; 31(3):731-734. PubMed ID: 27956738
    [No Abstract]   [Full Text] [Related]  

  • 26. Extramedullary relapse and discordant CD19 expression between bone marrow and extramedullary sites in relapsed acute lymphoblastic leukemia after blinatumomab treatment.
    Demosthenous C; Lalayanni C; Iskas M; Douka V; Pastelli N; Anagnostopoulos A
    Curr Probl Cancer; 2019 Jun; 43(3):222-227. PubMed ID: 29895435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD20 and Outcome of Childhood Precursor B-cell Acute Lymphoblastic Leukemia: A Meta-analysis.
    Ou DY; Luo JM; Ou DL
    J Pediatr Hematol Oncol; 2015 Apr; 37(3):e138-42. PubMed ID: 25222059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Maintenance therapy following CD19 CAR-T treatment for relapsed B-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation].
    Jiang YL; Li Q; Pu YD; Jiang YY; Yuan T; Deng Q; Li YM; Han MZ; Zhai WH
    Zhonghua Xue Ye Xue Za Zhi; 2020 Jun; 41(6):495-501. PubMed ID: 32654464
    [No Abstract]   [Full Text] [Related]  

  • 29. Lack of expression of the chondroitin sulphate proteoglycan neuron-glial antigen 2 on candidate stem cell populations in paediatric acute myeloid leukaemia/abn(11q23) and acute lymphoblastic leukaemia/t(4;11).
    Neudenberger J; Hotfilder M; Rosemann A; Langebrake C; Reinhardt D; Pieters R; Schrauder A; Schrappe M; Röttgers S; Harbott J; Vormoor J
    Br J Haematol; 2006 May; 133(3):337-44. PubMed ID: 16643437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T cells raised against allogeneic HLA-A2/CD20 kill primary follicular lymphoma and acute lymphoblastic leukemia cells.
    Abrahamsen IW; Kjellevoll S; Greve-Isdahl M; Mensali N; Wälchli S; Kumari S; Loland BF; Egeland T; Kolstad A; Olweus J
    Int J Cancer; 2012 Apr; 130(8):1821-32. PubMed ID: 21630262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD9 correlates with cancer stem cell potentials in human B-acute lymphoblastic leukemia cells.
    Nishida H; Yamazaki H; Yamada T; Iwata S; Dang NH; Inukai T; Sugita K; Ikeda Y; Morimoto C
    Biochem Biophys Res Commun; 2009 Apr; 382(1):57-62. PubMed ID: 19254692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Proportions of cells expressing CD38-/CD34+, CD38+/CD34+, CD19+/CD34+, or CD13,33+/CD34+ in the regenerating bone marrows during complete remission of acute leukemia or after bone marrow transplantation].
    Kahng J; Shin SY; Han K
    Korean J Lab Med; 2007 Dec; 27(6):406-13. PubMed ID: 18160830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of cancer stem cell properties by CD9 in human B-acute lymphoblastic leukemia.
    Yamazaki H; Xu CW; Naito M; Nishida H; Okamoto T; Ghani FI; Iwata S; Inukai T; Sugita K; Morimoto C
    Biochem Biophys Res Commun; 2011 May; 409(1):14-21. PubMed ID: 21549094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-1-integrin expression in adult acute lymphoblastic leukemia: possible relationship with the stem cell antigen CD34.
    Cacciola RR; Stagno F; Impera S; Assisi AR; Cacciola E; Guglielmo P
    Acta Haematol; 1997; 97(1-2):63-6. PubMed ID: 8980611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BCP-ALL blasts are not dependent on CD19 expression for leukaemic maintenance.
    Weiland J; Pal D; Case M; Irving J; Ponthan F; Koschmieder S; Heidenreich O; von Stackelberg A; Eckert C; Vormoor J; Elder A
    Leukemia; 2016 Sep; 30(9):1920-3. PubMed ID: 27055873
    [No Abstract]   [Full Text] [Related]  

  • 36. Targeting primary human Ph(+) B-cell precursor leukemia-engrafted SCID mice using radiolabeled anti-CD19 monoclonal antibodies.
    Mitchell P; Lee FT; Hall C; Rigopoulos A; Smyth FE; Hekman AM; van Schijndel GM; Powles R; Brechbiel MW; Scott AM
    J Nucl Med; 2003 Jul; 44(7):1105-12. PubMed ID: 12843229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunophenotypic differences between putative hematopoietic stem cells and childhood B-cell precursor acute lymphoblastic leukemia cells.
    Lamkin T; Brooks J; Annett G; Roberts W; Weinberg K
    Leukemia; 1994 Nov; 8(11):1871-8. PubMed ID: 7526089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL.
    Lúcio P; Parreira A; van den Beemd MW; van Lochem EG; van Wering ER; Baars E; Porwit-MacDonald A; Bjorklund E; Gaipa G; Biondi A; Orfao A; Janossy G; van Dongen JJ; San Miguel JF
    Leukemia; 1999 Mar; 13(3):419-27. PubMed ID: 10086733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and nonhematopoietic origin.
    Bühring HJ; Kuçi S; Conze T; Rathke G; Bartolović K; Grünebach F; Scherl-Mostageer M; Brümmendorf TH; Schweifer N; Lammers R
    Stem Cells; 2004; 22(3):334-43. PubMed ID: 15153610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of clinical features and prognostic significance of CD20 positive childhood precursor B-lineage acute lymphoblastic leukemia].
    Nie SS; Zhao WL; Ji ZH
    Zhonghua Xue Ye Xue Za Zhi; 2011 Apr; 32(4):275-7. PubMed ID: 21569715
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.